Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000280478 | SCV000329195 | uncertain significance | not provided | 2016-03-14 | criteria provided, single submitter | clinical testing | The N852S variant in the NOD2 gene has been reported in several publications as a rare risk allele associated with Crohn disease in the Ashkenazi Jewish population (Tukel et al., (2004); King et al. (2006); Rivas et al., (2011); Zhang W et al., 2013). The NHLBI ESP Exome Sequencing Project reports N852S was observed with a frequency of 0.11% in 10/8600 alleles from individuals of European background, indicating it may be a rare (benign) variant in this population. The N852S variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret N852S in NOD2 as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001781424 | SCV000397287 | likely benign | Inflammatory bowel disease 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000336827 | SCV000397288 | likely benign | Blau syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV002513883 | SCV000759541 | association | Blau syndrome; Regional enteritis | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 852 of the NOD2 protein (p.Asn852Ser). This variant is present in population databases (rs104895467, gnomAD 1.6%), including at least one homozygous and/or hemizygous individual. In a large association analysis involving over 40,000 cases and controls (PMID: 21983784), individuals who carried this variant had a significantly increased risk of Crohn's disease (OR=2.47, 95% CI=1.55-3.93). ClinVar contains an entry for this variant (Variation ID: 97856). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt NOD2 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects NOD2 function (PMID: 21983784). In summary, this is a common variant that is associated with an increased risk for developing disease. For these reasons, this variant has been classified as an Increased Risk Allele. |
ARUP Laboratories, |
RCV000280478 | SCV002049728 | likely benign | not provided | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002260984 | SCV002542702 | likely benign | Autoinflammatory syndrome | 2021-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000280478 | SCV002563338 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | NOD2: BP4, BS1, BS2 |
Unité médicale des maladies autoinflammatoires, |
RCV000336827 | SCV000116244 | not provided | Blau syndrome | no assertion provided | not provided | ||
Genome Diagnostics Laboratory, |
RCV000280478 | SCV001930578 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000280478 | SCV001974024 | likely benign | not provided | no assertion criteria provided | clinical testing |